Media OutReach
Vinmec Launches Vietnam’s First Integrated High-Tech Robotic Surgery Network, Establishing the Country’s First Multi-Connected Robotic Surgery Ecosystem
The defining feature of the new network is Vietnam’s first and only multi-connected robotic surgery ecosystem. Rather than deploying standalone robotic systems, Vinmec has established an integrated operating platform that brings together multiple world-leading robotic technologies across its hospital network. Vinmec Times City International Hospital serves as the clinical coordination hub, linking robotic surgery centers at Vinmec Smart City, Vinmec Da Nang, Vinmec Central Park, Vinmec Can Tho and other Vinmec hospitals throughout the country.
For general surgery, Vinmec operates three of the world’s leading robotic surgery platforms: Da Vinci Xi at Vinmec Times City, Hugo RAS at Vinmec Da Nang and Vinmec Central Park, and Toumai MT-1000 at Vinmec Smart City and Vinmec Can Tho. Together, these technologies enable surgeons to access deep anatomical structures, perform highly precise procedures within confined surgical spaces, and select the most appropriate platform based on each patient’s condition. Notably, the Toumai MT-1000 also introduces the capability for 5G-enabled remote robotic surgery, laying the foundation for future models of connected healthcare delivery.
In orthopedic surgery, Vinmec has deployed a comprehensive portfolio of next-generation joint replacement robots, including ROSA at Vinmec Smart City, MISSO at Vinmec Times City and Vinmec Can Tho, and CORI across Vinmec Ocean Park 2, Hai Phong, Da Nang, Central Park, Phu Quoc and Nha Trang. These technologies enable personalized surgical planning based on each patient’s anatomy while supporting millimeter-level precision in implant positioning and joint balancing, helping optimize clinical outcomes and accelerate postoperative recovery.
For neurosurgery and spine surgery, Vinmec has integrated the StealthStation S8, Mazor X Stealth Edition robotic guidance system and the O-arm with StealthStation O2 imaging platform at Vinmec Smart City and Vinmec Da Nang. This advanced technology suite provides real-time navigation, intraoperative imaging and continuous surgical verification, enabling surgeons to accurately access complex anatomical structures while improving procedural safety and reducing the risk of complications.
Complementing its advanced technology ecosystem, Vinmec is also the first healthcare provider in Vietnam to develop a “3-in-1” robotic surgery model built on Personalization, Automation and Standardization. Every patient receives an individualized treatment plan through preoperative 3D reconstruction and surgical simulation, benefits from AI-enabled robotic assistance during surgery, and is treated according to internationally recognized standards in clinical practice, education and research.
Technology delivers value only when placed in the hands of highly skilled professionals. To operate this large-scale robotic surgery ecosystem, Vinmec has developed a multidisciplinary team of specialists who have undergone rigorous training, competency assessments and international robotic surgery certification programs. Their expertise forms the foundation for delivering safe, high-quality and consistently effective surgical care.
Alongside the launch of the robotic surgery network, Vinmec also announced the establishment of the Robotic Surgery Patient Support Fund, backed by nearly VND 300 billion in funding from Vingroup. The fund is expected to reduce financial barriers and expand patient access to advanced robotic surgery, particularly for those facing financial hardship.
At the event, Prof. Tran Van Thuan, MD, PhD, Deputy Minister of Health, remarked: “I highly appreciate Vinmec’s vision of not only investing in advanced medical equipment but also building a comprehensive ecosystem encompassing clinical care, medical education, scientific research, technology transfer, and international collaboration.” The Deputy Minister also acknowledged the humanitarian value of the Robotic Surgery Patient Support Fund, which helps expand access to advanced surgical technologies for eligible patients.
Speaking at the launch ceremony, Prof. Tran Trung Dung, MD, PhD, Chief Executive Officer of Vinmec Healthcare System, said:
“Our High-Tech Robotic Surgery Network is built on a model of multidimensional connectivity connecting experts, hospitals and the world’s leading technology partners within a single integrated ecosystem. Our goal is to provide patients in Vietnam with access to the most advanced surgical innovations while progressively positioning Vietnam as a regional destination for high-tech healthcare and precision surgery.”
According to Assoc. Prof. Pham Van Binh, MD, PhD, Director of the Vinmec High-Tech Robotic Surgery Network, the true strength of the centers lies not only in their advanced robotic systems but also in their ability to transform technology into sustainable clinical excellence.
“Our vision extends beyond building a treatment center. We are establishing an academic institution for robotic surgery that integrates clinical practice, academic training, scientific research and technology transfer, bringing together leading robotic surgeons from Vietnam and around the world.”
The launch of Vinmec’s High-Tech Robotic Surgery Network represents not only a significant milestone in the healthcare system’s development but also an important step forward in accelerating Vietnam’s transition toward an era of precision, personalized and technology-driven surgery. By bringing world-class surgical innovation closer to patients, Vinmec is laying the foundation for Vietnam to emerge as a new regional hub for robotic surgery and advanced medical treatment in Southeast Asia.
Hashtag: #Vinmec
The issuer is solely responsible for the content of this announcement.
Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.
ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.
In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.
Acquisitions Support Service Network Expansion
ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.
In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.
By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.
Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.
The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.
Hashtag: #ZenaTech
The issuer is solely responsible for the content of this announcement.
About ZenaTech
ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.
Media OutReach
A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04
Hashtag: #SPOTMAS
https://spotmas.com.hk/The issuer is solely responsible for the content of this announcement.
Media OutReach
St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys
Overview of the WACE Curriculum at SFMS
SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.
SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.
Academic Outcomes and University Placements
In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.
In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.
Student Journeys and Holistic Development
Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.
Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.
Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.
These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational
https://www.sfms.edu.sg/
https://www.facebook.com/sfms.singapore
https://www.instagram.com/sfms_sg/
https://www.youtube.com/channel/UC_bb9hcNhAk7WgYBE_FI61A/featured
The issuer is solely responsible for the content of this announcement.
About St Francis Methodist School International
Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.
